Mumbai based, RPG Life Sciences, an integrated pharmaceutical company operating in the domestic and international markets in the branded formulations, global generics, synthetic and fermentation APIs space, has roped in C T Renganathan as its new chief.
Renganathan is joining the board as an additional director besides being named as the managing director for a term of three years, as per a stock market disclosure.
Renganathan has been working in the pharmaceutical industry for the last 30 years in different capacities of sales, marketing and general management, both in India as well as international markets such as Malaysia, Singapore and Brunei.
His previous companies include GSK India, Boston Scientific and Eli Lilly. In the last assignment he was one of the three executive vice presidents of GlaxoSmithKline Pharmaceuticals.
Renganathan is taking over a position vacant since September when Ajit Singh Chouhan resigned as the managing director. Chouhan had continued as a director but has now stepped down from the board as well.
RPG Life Sciences is a part of Harsh Goenka-led RPG Enterprises.